1. Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report [ahead of print, 2020 May 27];Stockton;Am J Emerg Med,2020
2. Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU. [ahead of print, 2020 October 2];Zhao;Br J Anaesth,2020
3. Dexmedetomidine-associated hyperthermia: a series of 9 cases and a review of the literature;Krüger;Anesth Analg,2017
4. Dexmedetomidine-Associated Hyperpyrexia in Three Critically Ill Patients With Coronavirus Disease 2019;Czepiel;Crit Care Explor,2020
5. Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages. [ahead of print, 2020 Aug 26];Ammar;J Intensive Care Med,2020